Evidence map›Paper›PMID 40722390›Full record

ArticleBioengineering (Basel, Switzerland)2025

Adaptive RAG-Assisted MRI Platform (ARAMP) for Brain Metastasis Detection and Reporting: A Retrospective Evaluation Using Post-Contrast T1-Weighted Imaging.

Kuo-Chen Wu, Fatt Yang Chew, Kang-Lun Cheng, Wu-Chung Shen, Pei-Chun Yeh, Chia-Hung Kao, Wan-Yuo Guo, Shih-Sheng Chang

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kuo-Chen WuArtificial Intelligence Center, China Medical University Hospital, Taichung 40447, Taiwan.ORCID 0000-0001-9292-2819
Fatt Yang ChewDepartment of Medical Imaging, China Medical University Hospital, Taichung 40447, Taiwan.ORCID 0000-0002-8965-6131
Kang-Lun ChengDepartment of Medical Imaging, China Medical University Hospital, Taichung 40447, Taiwan.
Wu-Chung ShenDepartment of Medical Imaging, China Medical University Hospital, Taichung 40447, Taiwan.
Pei-Chun YehArtificial Intelligence Center, China Medical University Hospital, Taichung 40447, Taiwan.ORCID 0009-0004-7561-8304
Chia-Hung KaoArtificial Intelligence Center, China Medical University Hospital, Taichung 40447, Taiwan.
Wan-Yuo GuoArtificial Intelligence Center, China Medical University Hospital, Taichung 40447, Taiwan.ORCID 0000-0003-2640-8664
Shih-Sheng ChangArtificial Intelligence Center, China Medical University Hospital, Taichung 40447, Taiwan.

Funding

China Medical University Hospital DMR-114-001, DMR-114-006
6 · The paper itself

Abstract

This study aimed to develop and evaluate an AI-driven platform, the Adaptive RAG Assistant MRI Platform (ARAMP), for assisting in the diagnosis and reporting of brain metastases using post-contrast axial T1-weighted (AX_T1+C) MRI. In this retrospective study, 2447 cancer patients who underwent MRI between 2010 and 2022 were screened. A subset of 100 randomized patients with confirmed brain metastases and 100 matched non-cancer controls were selected for evaluation. ARAMP integrates quantitative radiomic feature extraction with an adaptive Retrieval-Augmented Generation (RAG) framework based on a large language model (LLM, GPT-4o), incorporating five authoritative medical references. Three board-certified neuroradiologists and an independent LLM (Gemini 2.0 Pro) assessed ARAMP performance. Metrics of the assessment included Pre-/Post-Trained Inference Difference, Inter-Inference Agreement, and Sensitivity. Post-training, ARAMP achieved a mean Inference Similarity score of 67.45%. Inter-Inference Agreement among radiologists averaged 30.20% (

Indexed as

axial T1-weightedbrain metastasesMRIradiologicalretrieval-augmented generation

Identifiers

PMID40722390
PMCPMC12292328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.